<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Vaccine</journal-id><journal-id journal-id-type="iso-abbrev">Vaccine</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Vaccine</journal-title></journal-title-group><issn pub-type="ppub">0264-410X</issn><issn pub-type="epub">1873-2518</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC8730362</article-id><article-id pub-id-type="pmcid-ver">PMC8730362.1</article-id><article-id pub-id-type="pmcaid">8730362</article-id><article-id pub-id-type="pmcaiid">8730362</article-id><article-id pub-id-type="manuscript-id">NIHMS1654865</article-id><article-id pub-id-type="pmid">33328142</article-id><article-id pub-id-type="doi">10.1016/j.vaccine.2020.11.033</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1654865</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1654865</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Evaluation of the safety profile of the vaccine candidate <italic toggle="yes">Brucella melitensis</italic> 16M&#916;<italic toggle="yes">vjb</italic>R strain in goats</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Casta&#241;o-Zubieta</surname><given-names initials="MR">M. Raquel</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref rid="FN1" ref-type="author-notes">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rossetti</surname><given-names initials="CA">Carlos A.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref rid="FN1" ref-type="author-notes">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Garc&#237;a-Gonz&#225;lez</surname><given-names initials="DG">Daniel G.</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Maurizio</surname><given-names initials="E">Estefan&#237;a</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hensel</surname><given-names initials="ME">Martha E.</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rice-Ficht</surname><given-names initials="AC">Allison C.</given-names></name><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ficht</surname><given-names initials="TA">Thomas A.</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Arenas-Gamboa</surname><given-names initials="&#xC1;M">&#193;ngela M.</given-names></name><xref ref-type="aff" rid="A2">2</xref><xref rid="CR1" ref-type="corresp">*</xref></contrib></contrib-group><aff id="A1"><label>1</label>Instituto de Patobiolog&#237;a, CICVyA-INTA (Instituto Nacional de Tecnolog&#237;a Agropecuaria). Nicolas Repetto y de Los Reseros s/n (B1686), Hurlingham, Bs. As., Argentina.</aff><aff id="A2"><label>2</label>Department of Veterinary Pathobiology, College of Veterinary Medicine &amp; Biomedical Sciences, Texas A&amp;M University, 4467 TAMU, College Station, TX 77843, USA.</aff><aff id="A3"><label>3</label>CONICET. Godoy Cruz 2290 (C1425) CABA, Argentina</aff><aff id="A4"><label>4</label>Department of Molecular and Cellular Medicine, College of Medicine, Texas A&amp;M University, College Station, TX 77843, USA</aff><author-notes><fn fn-type="equal" id="FN1"><label>a</label><p id="P1">Both authors contributed equally to this manuscript</p></fn><corresp id="CR1"><label>*</label>Corresponding author: Angela M. Arenas-Gamboa, Department of Veterinary Pathobiology, College of Veterinary Medicine&amp; Biomedical Sciences, Texas A&amp;M University, College-Station, TX, USA. TeleFax: +1 979-862-1764, <email>aarenas@cvm.tamu.edu</email></corresp><fn fn-type="COI-statement" id="FN2"><p id="P50">Declaration of Competing Interest</p><p id="P51">The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Allison Rice-Ficht, managing partner of NanoRelease Technologies (NRT), LLC Inc., has a 95% equity interest in NRT, a company involved in vaccine delivery platforms. The terms of this arrangement have been reviewed and approved by TXAgriLife Research and Texas A&amp;M University in accordance with their conflict of interest policies.</p></fn></author-notes><pub-date pub-type="epub"><day>13</day><month>12</month><year>2020</year></pub-date><pub-date pub-type="ppub"><day>15</day><month>1</month><year>2021</year></pub-date><volume>39</volume><issue>3</issue><issue-id pub-id-type="pmc-issue-id">397304</issue-id><fpage>617</fpage><lpage>625</lpage><pub-history><event event-type="nihms-submitted"><date><day>23</day><month>12</month><year>2021</year></date></event><event event-type="pmc-release"><date><day>15</day><month>01</month><year>2022</year></date></event><event event-type="pmc-live"><date><day>15</day><month>01</month><year>2022</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-11 16:25:31.347"><day>11</day><month>06</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1654865.pdf"/><abstract id="ABS1"><p id="P2">Small ruminant brucellosis is caused by the Gram negative cocci-bacillus <italic toggle="yes">Brucella</italic> (<italic toggle="yes">B.) melitensis,</italic> the most virulent <italic toggle="yes">Brucella</italic> species for humans. In goats and sheep, middle to late-term gestation abortion, stillbirths and the delivery of weak infected offspring are the characteristic clinical signs of the disease. Vaccination with the currently available Rev. 1 vaccine is the best option to prevent and control the disease, although it is far from ideal. In this study, we investigate the safety of the <italic toggle="yes">B. melitensis</italic> 16M&#916;<italic toggle="yes">vjbR</italic> strain during a 15-month period beginning at vaccination of young goats, impregnation, delivery and lactation. Forty, 4 to 6 months old, healthy female crossbreed goats were randomly divided into four groups (<italic toggle="yes">n</italic>=10) and immunized subcutaneously with a single vaccine dose containing 1&#215;10<sup>9</sup> CFU of <italic toggle="yes">B. melitensis</italic> 16M&#916;<italic toggle="yes">vjbR</italic> delivered in alginate microcapsules or non-encapsulated. Controls received empty capsules or the commercially available Rev.1 vaccine. Seven months post-vaccination, when animals were sexually mature, all goats were naturally bred using brucellosis-free males, and allowed to carry pregnancies to term. Blood samples to assess the humoral immune response were collected throughout the study. At two months post-delivery, all dams and their offspring were euthanized and a necropsy was performed to collect samples for bacteriology and histology. Interestingly, none of the animals that received the vaccine candidate regardless of the formulation exhibited any clinical signs associated with vaccination nor shed the vaccine strain through saliva, vagina or the milk. Gross and histopathologic changes in all nannies and offspring were unremarkable with no evidence of tissue colonization or vertical transmission to fetuses. Altogether, these data demonstrate that vaccination with the mutant strain 16M&#916;<italic toggle="yes">vjb</italic>R is safe for use in the non-pregnant primary host.</p></abstract><kwd-group><kwd>Brucella</kwd><kwd>brucellosis</kwd><kwd>vaccine</kwd><kwd>microencapsulation</kwd><kwd>goats</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>